V

Virax Biolabs Group Ltd
NASDAQ:VRAX

Watchlist Manager
Virax Biolabs Group Ltd
NASDAQ:VRAX
Watchlist
Price: 0.2091 USD -3.73% Market Closed
Market Cap: $1.4m

Profitability Summary

Virax Biolabs Group Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Virax Biolabs Group Ltd

Margins Comparison
Virax Biolabs Group Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
UK
Virax Biolabs Group Ltd
NASDAQ:VRAX
1.4m USD
Loading...
Loading...
Loading...
US
Mckesson Corp
NYSE:MCK
115.3B USD
Loading...
Loading...
Loading...
US
Amerisourcebergen Corp
LSE:0HF3
68.5B USD
Loading...
Loading...
Loading...
US
Cencora Inc
NYSE:COR
70B USD
Loading...
Loading...
Loading...
US
Cardinal Health Inc
NYSE:CAH
51.9B USD
Loading...
Loading...
Loading...
AU
Sigma Healthcare Ltd
ASX:SIG
34.8B AUD
Loading...
Loading...
Loading...
US
Henry Schein Inc
NASDAQ:HSIC
9.3B USD
Loading...
Loading...
Loading...
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
63.8B CNY
Loading...
Loading...
Loading...
CN
Huadong Medicine Co Ltd
SZSE:000963
63.8B CNY
Loading...
Loading...
Loading...
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
Loading...
Loading...
Loading...
CN
Sinopharm Group Co Ltd
HKEX:1099
66.1B HKD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Virax Biolabs Group Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
UK
Virax Biolabs Group Ltd
NASDAQ:VRAX
1.4m USD
Loading...
Loading...
Loading...
Loading...
US
Mckesson Corp
NYSE:MCK
115.3B USD
Loading...
Loading...
Loading...
Loading...
US
Amerisourcebergen Corp
LSE:0HF3
68.5B USD
Loading...
Loading...
Loading...
Loading...
US
Cencora Inc
NYSE:COR
70B USD
Loading...
Loading...
Loading...
Loading...
US
Cardinal Health Inc
NYSE:CAH
51.9B USD
Loading...
Loading...
Loading...
Loading...
AU
Sigma Healthcare Ltd
ASX:SIG
34.8B AUD
Loading...
Loading...
Loading...
Loading...
US
Henry Schein Inc
NASDAQ:HSIC
9.3B USD
Loading...
Loading...
Loading...
Loading...
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
63.8B CNY
Loading...
Loading...
Loading...
Loading...
CN
Huadong Medicine Co Ltd
SZSE:000963
63.8B CNY
Loading...
Loading...
Loading...
Loading...
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
Loading...
Loading...
Loading...
Loading...
CN
Sinopharm Group Co Ltd
HKEX:1099
66.1B HKD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Virax Biolabs Group Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate